MIR3118-2

Across TCGA pan-cancer cohorts, MIR3118-2 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated MIR3118-2 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MIR3118-2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3118-2 expression acts as an unfavorable survival marker.

SKCM are the cancer types where MIR3118-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.211	0.728	.023	27	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MIR3118-2–SKCM (DFS)

Open the SKCM breakdown →